Flu Vaccine Study
Participants needed: Healthy adults, age 18-64
Why are researchers doing this study?
Influenza (flu) is caused by a virus (a germ) and is spread by contact with nasal and oral secretions. Symptoms include sudden fever, headache, chills, muscle aches, and cough. The main strategy of prevention and control of flu is vaccination. The virus that causes flu usually changes a little bit each year. Therefore, the flu vaccine might change from year to year.
The purpose of this study is to determine whether one injection of the VLP study vaccine (tested at one dose level) gives protection from influenza, as well as to gather information on the safety (side effects), how well it’s tolerated, and immune response (protection level) of this one dose. The VLP vaccine is experimental, which means that it has not yet been approved for use or sale by regulatory authorities like Health Canada or the FDA in the United States. The data obtained with the VLP vaccine will be compared to the data obtained with a placebo.
Am I eligible to participate?
To be eligible to participate in this study, you must be:
- between 18 and 64 years old
- in good health
- available for study follow-up until April, 2018
What is my commitment as a study participant?
You will have at least one scheduled visit at the study site and you will receive follow-up phone calls from the study site after receiving the vaccination over approximately an eight to ten month period. The total time commitment is approximately eight to ten hours (depending on whether you are in the blood sample group). Participants will be compensated for their time and for out-of-pocket expenses, such as parking at the IWK Health Centre.
For more information, or to enroll in this study, please contact our study nurse, Trish Smith.
Contact Trish Smith